PMID- 27329608 OWN - NLM STAT- MEDLINE DCOM- 20180104 LR - 20181202 IS - 1476-5640 (Electronic) IS - 0954-3007 (Linking) VI - 70 IP - 11 DP - 2016 Nov TI - The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. PG - 1246-1253 LID - 10.1038/ejcn.2016.102 [doi] AB - A systematic review and meta-analysis were designed to evaluate the efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer. We searched the Cochrane Library, PubMed, EMBASE and Web of Science up to November 2015. We also hand searched the citation lists of included studies and previously identified systematic reviews to identify further relevant trials. Odds ratio (OR) was used to compare efficacy, and the pooled OR was estimated using a random effects model; heterogeneity was assessed with Cochran's Q and the Higgins' I(2)-test. Two reviewers assessed trial quality and extracted data independently. Analysis and bias for each included study were performed using Review Manager 5.2. Nine randomized and placebo-controlled studies (N=1265 participants) were included for assessing efficacy, of which seven were about radiotherapy and two about chemotherapy. Probiotic groups were compared with control groups with respect to the the incidence of diarrhea, OR=0.47 (95% confidence interval 0.28-0.76; P=0.002). Eleven studies, including 1612 people (873 consuming probiotics and 739 not consuming probiotics), were used for the analysis of safety of probiotics. Of the 11 studies, seven studies had no adverse events (AEs) caused by probiotics, whereas four studies reported varying degrees of AEs in their treatment. Probiotics may have a beneficial effect in prevention of chemoradiotherapy-induced diarrhea generally, especially for Gradeā©¾2 diarrhea. Probiotics may rarely cause AEs. FAU - Wang, Y-H AU - Wang YH AD - The First Clinical Medical College of Lanzhou University, Lanzhou, China. AD - Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. FAU - Yao, N AU - Yao N AD - Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. FAU - Wei, K-K AU - Wei KK AD - The First Clinical Medical College of Lanzhou University, Lanzhou, China. AD - Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. FAU - Jiang, L AU - Jiang L AD - Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China. FAU - Hanif, S AU - Hanif S AD - The First Clinical Medical College of Lanzhou University, Lanzhou, China. FAU - Wang, Z-X AU - Wang ZX AD - The First Clinical Medical College of Lanzhou University, Lanzhou, China. AD - Evidence Based Medical Centre of Lanzhou University, Lanzhou, China. FAU - Pei, C-X AU - Pei CX AD - The First Clinical Medical College of Lanzhou University, Lanzhou, China. AD - Evidence Based Medical Centre of Lanzhou University, Lanzhou, China. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review PT - Systematic Review DEP - 20160622 PL - England TA - Eur J Clin Nutr JT - European journal of clinical nutrition JID - 8804070 SB - IM MH - Abdominal Neoplasms/drug therapy/radiotherapy MH - Diarrhea/prevention & control MH - Humans MH - Inflammatory Bowel Diseases/*prevention & control MH - Pelvic Neoplasms/drug therapy/radiotherapy MH - *Probiotics MH - Radiation Injuries/*prevention & control MH - Randomized Controlled Trials as Topic MH - Safety EDAT- 2016/11/03 06:00 MHDA- 2018/01/05 06:00 CRDT- 2016/06/23 06:00 PHST- 2015/12/17 00:00 [received] PHST- 2016/05/05 00:00 [revised] PHST- 2016/05/14 00:00 [accepted] PHST- 2016/11/03 06:00 [pubmed] PHST- 2018/01/05 06:00 [medline] PHST- 2016/06/23 06:00 [entrez] AID - ejcn2016102 [pii] AID - 10.1038/ejcn.2016.102 [doi] PST - ppublish SO - Eur J Clin Nutr. 2016 Nov;70(11):1246-1253. doi: 10.1038/ejcn.2016.102. Epub 2016 Jun 22.